FDA DrugsClass II
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg...
Published: May 6, 2026Recall ID: D-0508-2026Category: drugsCountry: US
Reason for Recall / Hazard
cGMP deviations.
Product Description & Identification
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
Additional Source Details
| Field | Value |
|---|---|
| City | Houston |
| State | TX |
| Event id | 98694 |
| Address 1 | 9265 Kirby Dr |
| Code info | Lot 020226202150202, Exp Date 05/05/2026. |
| Postal code | 77054-2520 |
| Report date | 20260506 |
| Product type | Drugs |
| Product quantity | 50 syringes |
| Reason for recall | cGMP deviations. |
| Voluntary mandated | Voluntary: Firm initiated |
| Recall initiation date | 20260401 |
| Initial firm notification | Letter |
| Center classification date | 20260428 |
Overview
- Recalling FirmWells Pharma of Houston LLC
- StatusOngoing
- Risk LevelClass II
- DistributionU.S. Nationwide.